Though a role for Gal-3 as a positive regulator of β-catenin is well recognized [107,108,109,134,135,136], it is currently unclear how Gal-3 might induce the transcription of β-catenin target genes, such as Myc and cyclin D1 in BM-MSCs from patients with AML, since β-catenin was phosphorylated at S33/S37/T41. The gene discussed is LGALS3; the disease is acute myeloid leukemia.